VERAPAMIL HYDROCHLORIDE
- Product NDC
- 70518-4513
- 11-digit product format
- 705184513
- Labeler code
- 70518
- Product ID
- 70518-4513_42b0dc89-b6da-5a4b-e063-6394a90a56e4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- VERAPAMIL HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA206173
- Marketing category
- ANDA
- Marketing start
- 2025-11-01
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 180 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| V3888OEY5R | VERAPAMIL HYDROCHLORIDE | 152-11-4 | VERAPAMIL HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70518-4513-0 | 70518451300 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-4513-0) | 90 tablet | 2025-11-01 | No | No | Historical |